The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125022092 12502209 2 F 20160616 20160628 20160627 20160706 EXP PHHO2016SK008941 SANDOZ 92.65 YR F Y 58.00000 KG 20160706 MD SK SK

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125022092 12502209 1 PS RAMIPRIL. RAMIPRIL 1 Oral 2.5 MG, UNK 77514 2.5 MG
125022092 12502209 2 SS BLINDED NO TREATMENT RECEIVED INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 3 SS BLINDED PLACEBO INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 4 SS BLINDED RLX030 SERELAXIN 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 5 SS BLINDED NO TREATMENT RECEIVED INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 6 SS BLINDED PLACEBO INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 7 SS BLINDED RLX030 SERELAXIN 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0
125022092 12502209 8 SS AMLODIPIN AMLODIPINE BESYLATE 1 Oral 5 MG, UNK 0 5 MG
125022092 12502209 9 C VEROSPIRON SPIRONOLACTONE 1 Oral 25 MG, UNK 0 25 MG
125022092 12502209 10 C SPIRONOLACTONE. SPIRONOLACTONE 1 Oral 25 MG, UNK 0 25 MG
125022092 12502209 11 C BISOPROLOL BISOPROLOL 1 Oral 25 MG, UNK 0 25 MG
125022092 12502209 12 C ASPIRIN. ASPIRIN 1 Oral 20 MG, UNK 0 20 MG
125022092 12502209 13 C CONCOR BISOPROLOL FUMARATE 1 Unknown 2.5 MG, UNK 0 2.5 MG
125022092 12502209 14 C FUROSEMIDE. FUROSEMIDE 1 Oral 40 MG, UNK 0 40 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125022092 12502209 1 Cardiac failure
125022092 12502209 2 Cardiac failure acute
125022092 12502209 3 Cardiac failure acute
125022092 12502209 4 Cardiac failure acute
125022092 12502209 8 Hypertension
125022092 12502209 9 Cardiac failure
125022092 12502209 10 Cardiac failure
125022092 12502209 11 Cardiac failure
125022092 12502209 12 Prophylaxis
125022092 12502209 13 Cardiac failure
125022092 12502209 14 Cardiac failure

Outcome of event

Event ID CASEID OUTC COD
125022092 12502209 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125022092 12502209 Circulatory collapse
125022092 12502209 Dehydration
125022092 12502209 Hypotension

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125022092 12502209 1 20160607 20160616 0
125022092 12502209 2 20160608 20160608 0
125022092 12502209 3 20160608 20160608 0
125022092 12502209 4 20160608 20160608 0
125022092 12502209 5 20160610 20160610 0
125022092 12502209 6 20160610 20160610 0
125022092 12502209 7 20160610 20160610 0
125022092 12502209 8 20160616 0
125022092 12502209 9 20160607 0
125022092 12502209 10 20160609 0
125022092 12502209 11 20160609 0
125022092 12502209 13 20160609 0
125022092 12502209 14 20160609 0